National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 183 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome



Case Details

This is page 2 out of 19

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11   next


VAERS ID: 1198191 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-03-30
Onset:2021-04-04
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Acute respiratory failure, Asthenia, Endotracheal intubation, Guillain-Barre syndrome, Immunoglobulin therapy, Intervertebral disc degeneration, Lumbar puncture abnormal, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Mechanical ventilation, Muscular weakness, Scan with contrast abnormal, White matter lesion
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Angioedema (broad), Peripheral neuropathy (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Hypersensitivity (broad), Respiratory failure (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Atorvastatin, esomeprazole, folic acid, glyburide, Hydroxychloroquine, Januvia, metformin, methotrexate,
Current Illness: None
Preexisting Conditions: HTN, Type II DM, RA
Allergies: Morphine (hives/urticaria)
Diagnostic Lab Data: (4/10/2021) LP: albuminocytologic dissociation MRI brain: chronic white matter changes MRI C/T/L spine: lumbosacral nerve root enhancement, moderate degenerative changes
CDC Split Type:

Write-up: Patient developed progressive weakness and was diagnosed with Guillain-Barre Syndrome based on physical exam findings (ascending muscular weakness), lumbar puncture, and MRI findings. Disease course complicated by acute hypoxic respiratory failure which required endotracheal intubation and mechanical ventilation. He was treated with intravenous immunoglobulin x4 days.


VAERS ID: 1204072 (history)  
Form: Version 2.0  
Age: 24.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-03-04
Onset:2021-04-05
   Days after vaccination:32
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805031 / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Anaesthesia oral, Antinuclear antibody positive, Balance disorder, Blood albumin increased, CSF protein increased, Condition aggravated, Dry mouth, Gait disturbance, Guillain-Barre syndrome, Headache, Hyperaesthesia, Hypoaesthesia, Immunoglobulin therapy, Injection site discomfort, Laboratory test abnormal, Limb discomfort, Lumbar puncture abnormal, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Malaise, Pruritus, Temperature intolerance
SMQs:, Anaphylactic reaction (broad), Peripheral neuropathy (narrow), Systemic lupus erythematosus (narrow), Anticholinergic syndrome (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Vestibular disorders (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Creatine, multivitamins
Current Illness: None
Preexisting Conditions: none
Allergies: None
Diagnostic Lab Data: MRI, multiple antibody studies that are positive for antinuclear antibodies n Her 2, positive to dilution 1:40 and 1:160 on 4/6 and 1:40 on 4/9, elevated CDG protein and albumin.
CDC Split Type:

Write-up: Patient had an initial response 2 days after the vaccine, with general malaise, dry mouth, headache and itching hands as well as local discomfort at the injection site that seemed to resolve spontaneously. On April 3rd he had non-specific changes in his hands that he attributed to cold weather that led to discomfort when running them under warm water. By monday APril 5th he was having worsening sensitivity in his hands and feet to heat, touch and experienced numbness. he also began to have difficulty walking. He went to the ER April 6th and was discharged April 7th after undergoing MRI of the brain and spinal cord, labs and lumbar puncture, with a presumptive diagnosis of early Guillain-barre Syndrome. His symptoms continued to worse, loss of gait was more pronounced as well as loss of balance and new off sensations in his tongue. He was admitted to the hospital, continued to undergo diagnostic workout. Results from tests on APril 6th came back positive for Anti nuclear antibodies and high protein in his CSF. He was treated with 3 days of infused Immunoglobolin therapy and was discharged on April 11th with a diagnosis of likely GBS. His symptoms continue to worsen slightly, but with less day to day decline


VAERS ID: 1204923 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Female  
Location: Oregon  
Vaccinated:2021-03-12
Onset:2021-03-25
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1085018 / 1 UN / IM

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 19 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: apixaban (ELIQUIS) , cetirizine (ZYRTEC), digoxin, Ergocalciferol, Vitamin D2, furosemide, levothyroxine, potassium chloride (KLOR-CON M, VITAMIN B COMPLEX ORAL
Current Illness: heart failure, restrictive pericarditis
Preexisting Conditions: Hodgkins, BCL, afib, heart failure
Allergies: flecainide, amiodarone
Diagnostic Lab Data: Diagnosis of exclusion
CDC Split Type:

Write-up: Guillain-Barr? syndrome


VAERS ID: 1204953 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2021-03-15
Onset:2021-03-16
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1802070 / 1 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Axonal and demyelinating polyneuropathy, CSF test abnormal, Electromyogram abnormal, Guillain-Barre syndrome, Nerve conduction studies abnormal, Protein albumin ratio abnormal
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Combipatch, Buproprion, Tums, Adderall, Diazepam, Vitamin D, Folic acid, Sertraline, Trazodone
Current Illness: None
Preexisting Conditions: PTSD, dissociative disorder
Allergies: NSAIDs
Diagnostic Lab Data: CSF with cytoalbuminologic dissociation (protein of 242 and 7 nucleated cells). EMG/NCS consistent with acute inflammatory demyelinating and axonal polyneuropathy.
CDC Split Type:

Write-up: Patient was found to have Guillian-Barre Syndrome during admission beginning on 4/10/2021.


VAERS ID: 1207752 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-03-20
Onset:2021-04-02
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / 1 RA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Back pain, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral, Paraesthesia
SMQs:, Peripheral neuropathy (narrow), Retroperitoneal fibrosis (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Symptoms started 4/2/21. Stated as numbness and tingling in lower extremities and progressed to numbness of tongue and upper extremities along with back pain. Patient admitted to Hospital with R/O Guillian Barre Syndrome.


VAERS ID: 1214117 (history)  
Form: Version 2.0  
Age: 44.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-04-12
Onset:2021-04-14
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / UNK RA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Laboratory test, Pain in extremity
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: Yellow Fever Vaccine/2014
Other Medications: Vitamin D, K, Vitamin B complex Multivitamin Fish Oil
Current Illness: None
Preexisting Conditions: None
Allergies: Yellow Fever Vaccine
Diagnostic Lab Data: He received IV Toradol to help out with his extremity pain. Labs were checked to rule out electrolyte disturbance, thrombocytopenia. The patient''s neurologic examination does not demonstrate classic signs of Guillain-Barre, there is no evidence of muscle weakness or paralysis and his deep tendon reflexes are normal. Acute pain has been described in acute Guillain-Barre, and so I gave the patient return precautions regarding progressive symptoms. At this point, there are not enough objective criteria to diagnose him with GBS, symptoms do not suggest the need for hospitalization for observation. Even so, it is clear the severe extremity pain is a result of the vaccine.
CDC Split Type:

Write-up: Patient developed mild case of Guillain Barre Syndrome 34 hours after injection of the Johnson and Johnson vaccine. Patient has severe extremity pains. The patient has a personal history of being diagnosed with Guillain-Barre after a yellow fever vaccination.


VAERS ID: 1223655 (history)  
Form: Version 2.0  
Age: 63.0  
Sex: Male  
Location: Utah  
Vaccinated:2021-03-10
Onset:2021-03-13
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / UNK LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Fatigue, Guillain-Barre syndrome, Headache, Illness, Lumbar puncture abnormal, Magnetic resonance imaging, Muscular weakness, Pain in extremity, Paraesthesia, Ultrasound scan
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Hearing impairment (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: lisinopril pantoprazole
Current Illness: none
Preexisting Conditions: none
Allergies: penicillins, quinoloness
Diagnostic Lab Data: Several blood tests, mri''s, ct scan, spinal tap and ultra sound on neck. Put on anti viral and prednisone. Scheduled for infusion therapy.
CDC Split Type:

Write-up: tingling in hands and feet, headache, tired, bilateral bells palsy. Pain in arms and legs and weakness with extreme fatigue. Went to the ER, twice and was admitted. . Diagnosed with guillain-barr? syndrome. Still sick.


VAERS ID: 1230410 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Female  
Location: New York  
Vaccinated:2021-03-16
Onset:2021-04-04
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-04-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Asthenia, Dysarthria, Dysphagia, Epistaxis, Guillain-Barre syndrome, Headache, Mastication disorder, Myalgia, Pain in extremity
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Anticholinergic syndrome (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: unknown
Current Illness: unknown
Preexisting Conditions: diabetes, heart disease
Allergies: egg whites
Diagnostic Lab Data: unknown
CDC Split Type:

Write-up: Patient had slurred speech, headache, pain in the thigh muscles, bloody nose, lost strength in the arms, hands and legs, could not chew or swallow. She was diagnosed with Guillian Barre Syndrome and hospitalized from 04/04/2021-04/18/2021.


VAERS ID: 1232369 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: New York  
Vaccinated:2021-03-15
Onset:2021-04-07
   Days after vaccination:23
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Public       Purchased by: ?
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Guillain-Barre syndrome, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging, Nerve conduction studies abnormal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Hearing impairment (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Amlodipine 5 mg, Ramipril 10 mg, baby aspirin
Current Illness: None
Preexisting Conditions: High blood pressure - well under control with BP meds
Allergies: None
Diagnostic Lab Data: CT scan, multiple MRIs, lumbar puncture, nerve mapping test, blood tests to rule out Lyme, etc. Hospitalization testing and treatment is still ongoing.
CDC Split Type:

Write-up: Guillian-Barre Syndrome and Bell''s Palsy - inpatient hospitalization, treated with immunoglobulin infusion, transferred to another Hospital and awaiting further treatment


VAERS ID: 1234455 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-03-24
Onset:2021-04-01
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805022 / 1 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Bell's palsy, Facial paralysis, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture abnormal, Mastication disorder, Neurological symptom, Paraesthesia
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Gabapentin.
Current Illness: None. Was healthy at and prior to vaccination.
Preexisting Conditions: None.
Allergies: None
Diagnostic Lab Data: Lumbar puncture, 4/19/21, Guillain Barre syndrome with Bell?s palsy of the facial muscles.
CDC Split Type:

Write-up: One week after taking the vaccine the patient developed numbness and tingling in his face, hands, and feet. These symptoms progressed over time and on April 18, 2021, he presented to the ER with ?weird nerve symptoms,.? He remained there overnight and was admitted the next day., He was diagnosed by lumbar puncture with Bell?s palsy of the face secondary to Guillain Barre syndrome., He is presently still an inpatient there. He?s being treated with IV immunoglobulins, with no improvement. His eyes and facial muscles droop, and he has difficulty chewing food. The patient has no PCP but the hospital should be able to give you medical records of his admission. The patient and I both strongly support vaccines, and we were both eager to be vaccinated, but we don?t believe this rare illness has struck him with no precipitating event except the vaccine.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=2&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166